Buy Generic Alfuzosin Online
|
|
Generic Alfuzosin 10mg
Package | Price | Per Pill | Shipping | Order | |
10mg x 30 pills | $78.35 | $2.61 | Add to Cart | ||
10mg x 60 pills | $111.36 | $1.85 | Add to Cart | ||
10mg x 90 pills | $149.95 | $1.67 | Add to Cart | ||
10mg x 120 pills | $188.54 | $1.58 | Add to Cart | ||
10mg x 180 pills | $263.84 | $1.47 | Free Airmail shipping |
Add to Cart |
Generic Alfuzosin Information
Introduction
Alfuzosin is an oral α‑adrenergic blocker prescribed primarily for the treatment of benign prostatic hyper‑plasia (BPH) in adult men. In the United Kingdom it is listed on the NHS formulary and is commonly used to relieve urinary symptoms caused by an enlarged prostate. The active compound is alfuzosin, and the medication belongs to the Men’s Health group of drugs. Although its main indication is BPH, alfuzosin may be employed off‑label for certain bladder‑outlet obstruction conditions when clinically appropriate.
What is Alfuzosin?
Alfuzosin is a selective α₁‑adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck, improving urine flow. The drug was first approved in the United States in 200 and later received European Union marketing authorisation. The well‑known brand name for alfuzosin is Uroxatral (manufactured by Pfizer).
Alfuzosin is the generic version of Uroxatral, containing the same active compound Alfuzosin. Our online pharmacy provides this generic alternative as a cost‑effective treatment option. Generic formulations are produced by several qualified manufacturers under strict Good Manufacturing Practice (GMP) standards and are subject to the same regulatory scrutiny as the original brand.
How Alfuzosin Works
Alfuzosin binds competitively to α₁‑adrenergic receptors located on the smooth muscle of the prostate, bladder neck, and urethra. By blocking the action of endogenous catecholamines (primarily norepinephrine), the drug prevents calcium influx that would otherwise cause muscle contraction. The resulting relaxation of the lower urinary tract reduces urethral resistance and improves the rate of urine flow.
Key pharmacokinetic points:
- Onset of action: Symptomatic improvement is often observed within 2–4 weeks of daily dosing.
- Duration: Alfuzosin has a half‑life of roughly 8 hours, allowing for once‑daily administration.
- Metabolism: Primarily hepatic via CYP3A4; renal excretion accounts for a minor proportion of clearance.
- Food effect: The tablet formulation is designed for absorption with or without food, but taking it consistently with the same routine (e.g., after a meal) can minimise variability.
Conditions Treated with Alfuzosin
- Benign Prostatic Hyperplasia (BPH) – The principal indication. BPH affects up to 30 % of men aged 50–59 in the UK and rises to > 50 % after age 70. Alfuzosin relieves lower urinary tract symptoms (LUTS) such as hesitancy, weak stream, nocturia, and incomplete bladder emptying.
- Bladder‑Outlet Obstruction secondary to prostate enlargement – In selected patients where surgical intervention is deferred, alfuzosin can provide symptomatic relief.
- Off‑label Use for Urodynamic Studies – Occasionally employed to assess urethral tone during diagnostic investigations, though this practice is limited to specialist settings.
Clinical guidelines (NICE NG97, BPH management) recommend α‑blockers like alfuzosin as first‑line medical therapy for men with moderate to severe LUTS when immediate surgery is not indicated.
Who is Alfuzosin For?
Alfuzosin is appropriate for adult men who:
- Have a confirmed diagnosis of BPH with bothersome urinary symptoms affecting quality of life.
- Are able to swallow tablets whole and have no known contraindication to α‑blockade.
- Do not require immediate surgical reduction of prostate volume (e.g., severe acute urinary retention).
Situations where alfuzosin is generally avoided:
- History of orthostatic hypotension or severe cardiovascular disease (e.g., recent myocardial infarction).
- Concomitant use of potent CYP3A4 inhibitors such as ketoconazole, clarithromycin, or certain antifungal agents, which can raise alfuzosin plasma levels.
- Severe hepatic impairment (Child‑Pugh class C) because metabolism is reduced.
- Women and children, as safety and efficacy have not been established.
Risks, Side Effects, and Interactions
Common
- Dizziness, especially on standing (orthostatic hypotension).
- Headache.
- Nasal congestion or rhinorrhoea.
- Fatigue or generalised weakness.
Rare
- Priapism (prolonged painful erection).
- Intra‑operative floppy iris syndrome (relevant for men undergoing cataract surgery).
- Hepatic enzyme elevations (transaminases).
Serious
- Severe hypotension leading to syncope or falls, particularly in the elderly.
- Acute urinary retention (rare, but documented).
- Allergic reactions such as rash, angio‑edema, or anaphylaxis.
Drug–drug interactions
- CYP3A4 inhibitors (e.g., itraconazole, erythromycin, grapefruit juice) – may increase alfuzosin concentrations, raising the risk of hypotension.
- Other antihypertensives (e.g., ACE inhibitors, diuretics) – additive blood‑pressure‑lowering effect; monitoring is advised.
- Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) – combined use can potentiate vasodilatory effects; dose adjustment may be required.
Patients should disclose all current medications, including over‑the‑counter supplements, to their healthcare provider before initiating alfuzosin.
Practical Use: Dosing, Missed Dose, Overdose
- Standard dose: One 10 mg tablet taken once daily, preferably after the same meal each day to maintain consistent absorption.
- Dose adjustments: Not required for renal impairment; for moderate hepatic impairment (Child‑Pugh A/B), the same dose may be used with close monitoring.
- Missed dose: If a dose is forgotten, take it as soon as remembered provided it is at least 12 hours before the next scheduled dose. Otherwise, skip the missed dose and continue with the regular schedule; do not double‑dose.
- Overdose: Symptoms may include marked hypotension, dizziness, and syncope. If overdose is suspected, seek emergency medical attention immediately; supportive care with fluid resuscitation and vasopressors may be required.
- Alcohol: Moderate consumption does not generally affect alfuzosin, but excessive alcohol may exacerbate dizziness and hypotension.
- Food: High‑fat meals can slightly delay absorption but do not alter overall exposure; consistency is more important than strict fasting.
Buying Alfuzosin from Our Online Pharmacy
Patients in the United Kingdom can obtain alfuzosin through our online pharmacy. The service offers several advantages:
- Affordable pricing – Generic alfuzosin is supplied at near‑manufacturer cost, delivering a substantial saving compared with branded alternatives.
- Verified quality – All products are sourced from licensed overseas manufacturers that comply with European GMP standards and are inspected by independent quality‑control laboratories.
- Guaranteed delivery – Discreet packaging is shipped via a reliable courier network, with express options delivering within 7 days and standard air‑mail typically arriving in ≈ 3 weeks.
- Online‑only accessibility – The pharmacy broker model connects you with reputable international suppliers, ensuring continuity of supply even when local stock is limited.
- Privacy‑first approach – Personal data is encrypted and handled in accordance with the UK Data Protection Act, offering a confidential experience for those who value discretion.
Our pharmacy broker service enables patients who face limited access through conventional pharmacies or insurance schemes to obtain a trusted generic alternative safely and economically.
FAQ
-
Is alfuzosin available in both brand‑name and generic forms in the UK?
Yes. The original brand name is Uroxatral, produced by Pfizer. Genericuzosin tablets contain the same active ingredient and are approved by the MHRA, providing a more affordable option for patients. -
What colour and imprint are typical of alfuzosin tablets marketed in Europe?
Most European generic tablets are white or off‑white, oval‑shaped, and bear the imprint “10 mg” together with the manufacturer’s logo. However, exact appearance can vary between suppliers, so patients should verify the imprint with the dispensing pharmacist. -
Does alfuzosin require refrigeration or any special storage conditions?
No. Alfuzosin tablets should be stored at a controlled room temperature between 15 °C and 30 °C, protected from excess moisture and direct sunlight. Do not store in bathrooms or kitchen cabinets where humidity is high. -
Can I travel internationally with alfuzosin tablets in my hand luggage?
Yes. Alfuzosin is not classified as a controlled substance, so it may be carried in hand luggage for personal use. It is advisable to keep the medication in its original packaging with a copy of the prescription or a doctor’s note to avoid customs queries. -
Are there any known differences between alfuzosin formulations marketed in the US versus the EU?
The US FDA‑approved formulation is an extended‑release tablet containing 10 mg of alfuzosin hydrochloride, similar to the EU version. Minor differences may exist in inactive excipients (e.g., filler or binder types), but therapeutic equivalence is required by both regulatory agencies. -
What are the recommended precautions for patients with diabetes using alfuzosin?
Alfuzosin can cause orthostatic hypotension, which may mimic hypoglycaemic symptoms such as dizziness. Diabetic patients should monitor blood glucose closely when initiating therapy and be aware of the additive risk of low blood pressure, especially if they are on insulin or sulfonylureas. -
How does alfuzosin compare with other α‑blockers like tamsulosin or silodosin?
All three agents relax prostatic smooth muscle, but alfuzosin is non‑selective for α₁‑subtypes, whereas tamsulosin and silodosin are more selective for α₁‑A receptors, potentially resulting in fewer cardiovascular effects but a higher incidence of ejaculation disorders. Clinical choice depends on patient comorbidities and tolerance profiles. -
Is alfuzosin safe to use in patients with mild to moderate asthma?
Because alfuzosin acts primarily on vascular smooth muscle rather than bronchial smooth muscle, it is generally safe for asthmatic patients. However, any new medication should be introduced cautiously, and patients should report worsening respiratory symptoms promptly. -
What impact does grapefruit juice have on alfuzosin therapy?
Grapefruit juice inhibits CYP3A4 in the intestinal wall, which can increase alfuzosin plasma concentrations and raise the likelihood of hypotensive events. Patients are advised to avoid large quantities of grapefruit juice while taking alfuzosin. -
Are there any specific warnings for Asian populations taking alfuzosin?
Pharmacogenetic studies indicate that certain Asian sub‑populations may have slightly higher plasma levels of alfuzosin due to variations in CYP3A4 activity. Consequently, clinicians sometimes start with a lower dose (5 mg) and titrate upward based on response and tolerability. -
Can alfuzosin affect results of routine drug testing (e.g., for employment)?
Alfuzosin does not belong to common drug‑screening panels (opioids, cannabinoids, amphetamines, etc.) and is unlikely to produce a false‑positive result in standard occupational drug tests. -
What should I do if I experience persistent nasal congestion while on alfuzosin?
Nasal congestion is a reported side effect due to α‑blockade of nasal mucosal vessels. If the symptom is bothersome, discuss with a healthcare professional; a short course of a decongestant or switching to a more selective α‑blocker may be considered.
Glossary
- α₁‑adrenergic receptor
- A protein on smooth‑muscle cells that binds norepinephrine, causing contraction. Blocking this receptor leads to muscle relaxation, especially in the prostate and bladder neck.
- Benign Prostatic Hyperplasia (BPH)
- A non‑cancerous enlargement of the prostate gland common in older men, which can obstruct urine flow and cause lower urinary tract symptoms.
- Orthostatic hypotension
- A drop in blood pressure that occurs when a person stands up quickly, leading to dizziness or fainting.
⚠️ Disclaimer
The information provided about Alfuzosin is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Alfuzosin for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.